TerezaMartinuMD
Pulmonology • Lumberton, NCCritical Care Medicine
Assistant Professor, Medicine, Duke University School of Medicine
Are you Dr. Martinu?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 42 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
300 W 27th St
Lumberton, NC 28358Phone+1 910-671-5000Fax+1 919-684-5266
Summary
- Dr. Tereza Martinu, MD is a pulmonologist in Lumberton, North Carolina. She is currently licensed to practice medicine in North Carolina and Illinois. She is an Assistant Professor at Duke University School of Medicine.
Education & Training
Duke University HospitalFellowship, Pulmonary Disease and Critical Care Medicine, 2005 - 2008- Duke University HospitalResidency, Internal Medicine, 2002 - 2005
McGill University Faculty of MedicineClass of 2002
Certifications & Licensure
NC State Medical License 2005 - 2025
IL State Medical License 2019 - 2023
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Publications & Presentations
PubMed
- Prognosis and Risks for Probable Chronic Lung Allograft Dysfunction: A Prospective Multicenter Study.Jamie L Todd, S Sam Weigt, Megan L Neely, Maria V Grau-Sepulveda, Kristen Mason
American Journal of Respiratory and Critical Care Medicine. 2025-02-01 - Detailed cellular and spatial characterization of chronic lung allograft dysfunction using imaging mass cytometry.Benjamin Renaud-Picard, Sajad Moshkelgosha, Gregory Berra, May Cheung, David Hwang
The Journal of Heart and Lung Transplantation. 2025-01-01 - Local intragraft humoral immune responses in chronic lung allograft dysfunction.Ei Miyamoto, Daniel Vosoughi, Jinguo Wang, Jamal Al-Refaee, Gregory Berra
The Journal of Heart and Lung Transplantation. 2025-01-01
Press Mentions
IL‐6 Receptor Blockade for Allograft Dysfunction After Lung Transplantation in a Patient with COPA SyndromeJanuary 28th, 2021
ISHLT Elects New Board MembersJanuary 7th, 2021
Ontario Boy Almost Needed Double-Lung Transplant After Vaping: DoctorsNovember 21st, 2019- Join now to see all
Grant Support
- Role Of CXC Chemokines At The Innate-Adaptive Interface Of Alloimmune Lung InjuryNational Heart, Lung, And Blood Institute2007
